Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion
This comprehensive review examines the unique attributes, distinctions, and clinical implications of ceftazidime–avibactam (CAZ-AVI) and meropenem–vaborbactam (MEM-VAB) against difficult-to-treat <i>Enterobacterales</i> infections. Our manuscript explores these antibiotics’ pharmacokinet...
| Published in: | Antibiotics |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-10-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/12/10/1521 |
